BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 9310346)

  • 1. Enamel matrix derivative promotes superoxide production and chemotaxis but reduces matrix metalloproteinase-8 expression by polymorphonuclear leukocytes.
    Karima MM; Van Dyke TE
    J Periodontol; 2012 Jun; 83(6):780-6. PubMed ID: 22050547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Microparticle Release and Pro-Inflammatory Properties of Activated Human Polymorphonuclear Neutrophils by LMW Fucoidan.
    Moraes JA; Frony AC; Barcellos-de-Souza P; Menezes da Cunha M; Brasil Barbosa Calcia T; Benjamim CF; Boisson-Vidal C; Barja-Fidalgo C
    J Innate Immun; 2019; 11(4):330-346. PubMed ID: 30557873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-alpha) production on lipopolysaccharide (LPS)-stimulated human neutrophils.
    Vulcano M; Alves Rosa MF; Minnucci FS; Cherñavsky AC; Isturiz MA
    Clin Exp Immunol; 1998 Jul; 113(1):39-47. PubMed ID: 9697981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nano-carriers with N-formylmethionyl-leucyl-phenylalanine-modified liposomes improve effects of C16-angiopoietin 1 in acute animal model of multiple sclerosis.
    Fu XX; Qu H; Wang J; Cai HY; Jiang H; Chen HH; Han S
    Drug Deliv; 2023 Dec; 30(1):2241664. PubMed ID: 37545034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorphins-From Discovery to Functions and Pharmacology.
    Mielczarek P; Hartman K; Drabik A; Hung HY; Huang EY; Gibula-Tarlowska E; Kotlinska JH; Silberring J
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34201982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.
    He HQ; Ye RD
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28335409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.
    Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
    Int Immunopharmacol; 2016 Aug; 37():43-58. PubMed ID: 26382576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?
    Mizerska-Dudka M; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):197-205. PubMed ID: 25193979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorphins act as homeostatic agents in response to endotoxin-induced stress.
    Barkhudaryan N; Zakaryan H; Sarukhanyan F; Gabrielyan A; Dosch D; Kellermann J; Lottspeich F
    Neurochem Res; 2010 Jun; 35(6):925-33. PubMed ID: 19967445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.
    Ye RD; Boulay F; Wang JM; Dahlgren C; Gerard C; Parmentier M; Serhan CN; Murphy PM
    Pharmacol Rev; 2009 Jun; 61(2):119-61. PubMed ID: 19498085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation.
    Yamamoto Y; Ono H; Ueda A; Shimamura M; Nishimura K; Hazato T
    Curr Protein Pept Sci; 2002 Dec; 3(6):587-99. PubMed ID: 12470213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists.
    Dalpiaz A; Spisani S; Biondi C; Fabbri E; Nalli M; Ferretti ME
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):33-42. PubMed ID: 12570724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
    Yamamoto Y; Kanazawa T; Shimamura M; Ueki M; Hazato T
    Biochem Pharmacol; 1997 Sep; 54(6):695-701. PubMed ID: 9310346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
    Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
    J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.